AmnioFix®
Phase 2Withdrawn 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Prostate Cancer
Conditions
Prostate Cancer
Trial Timeline
Nov 1, 2016 → —
NCT ID
NCT02645591About AmnioFix®
AmnioFix® is a phase 2 stage product being developed by MiMedx Group for Prostate Cancer. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02645591. Target conditions include Prostate Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Prostate Cancer were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02645591 | Phase 2 | Withdrawn |
Competing Products
20 competing products in Prostate Cancer